{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:49:07Z","timestamp":1757314147213},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brazilian National Research Council"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Erectile dysfunction (ED) occurs in more than 50% of patients with human T-cell lymphotropic virus type 1 (HTLV-1) infection. In the general population, atherosclerosis is the main risk factor related to ED.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To compare the contribution of neurologic disorders from HTLV-1 with that of atherosclerosis as risk factors for ED in men with HTLV-1.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this cross-sectional study, men 18 to 70 years old with HTLV-1 were classified into one of two groups according to the presence or absence of ED. They were compared for obesity, waist circumference, dyslipidemia, metabolic syndrome, diabetes mellitus, high blood pressure, and neurologic manifestations. Comparisons between proportions were performed using the \u03c72 or Fisher exact test. Logistic regression analysis was performed to identify predictors of ED. Subjects with HTLV-1 were classified into three groups based on Osame's Disability Motor Scale and the Expanded Disability Status Scale: (i) HTLV-1 carriers; (ii) probable HTLV-1\u2013associated myelopathy or tropical spastic paraparesis; and (iii) definitive HTLV-1\u2013associated myelopathy or tropical spastic paraparesis. The International Index of Erectile Function was used to determine the degree of ED.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In univariate logistic regression, age older 60 years (P\u00a0= .003), diabetes mellitus (P\u00a0= .042), and neurologic disease (P &amp;lt; .001) were associated with ED. In the multivariate model, the odds of ED was highest in patients with neurologic disease (odds ratio\u00a0= 22.1, 95% CI\u00a0= 5.3\u201392.3), followed by high blood pressure (odds ratio\u00a0= 6.3, 95% CI\u00a0= 1.4-30.5) and age older than 60 years (odds ratio\u00a0= 4.6, 95% CI\u00a0= 1.3\u201317.3).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>In men infected with HTLV-1, neurologic dysfunction is a stronger predictor of ED than risk factors for atherosclerosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>The small number of patients limited the power of the statistical analysis, but clearly neurologic manifestations had a greater association with ED than risk factors for atherosclerosis, and there was no association between metabolic syndrome and severity of ED.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Neurologic impairment is the major cause of ED in individuals infected with HTLV-1 and risk factors for atherosclerosis did not have a strong relation with ED in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T01:31:11Z","timestamp":1503106271000},"page":"1195-1200","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk Factors for Erectile Dysfunction in Men with HTLV-1"],"prefix":"10.1093","volume":"14","author":[{"given":"Cassius Jos\u00e9 Vitor","family":"de Oliveira","sequence":"first","affiliation":[{"name":"Postgraduate Program in Health Sciences \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia School of Medicine \u00a0 , Salvador, Bahia , Brazil"},{"name":"Immunology Service \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"University Hospital Professor Edgard Santos \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia \u00a0 \u00a0 , Salvador, Bahia , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Abra\u00e3o Carneiro","family":"Neto","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Health Sciences \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia School of Medicine \u00a0 , Salvador, Bahia , Brazil"},{"name":"Immunology Service \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"University Hospital Professor Edgard Santos \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia \u00a0 \u00a0 , Salvador, Bahia , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana C.P.","family":"Andrade","sequence":"additional","affiliation":[{"name":"Immunology Service \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"University Hospital Professor Edgard Santos \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Physical Therapy Department \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"University Hospital Professor Edgard Santos \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia \u00a0 \u00a0 , Salvador, Bahia , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Novis","family":"Rocha","sequence":"additional","affiliation":[{"name":"Department of Medicine and Diagnostic Support \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia School of Medicine \u00a0 , Salvador, Bahia , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar Marcelino","family":"de Carvalho Filho","sequence":"additional","affiliation":[{"name":"Immunology Service \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"University Hospital Professor Edgard Santos \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia \u00a0 \u00a0 , Salvador, Bahia , Brazil"},{"name":"Department of Medicine and Diagnostic Support \u00a0 , Salvador, Bahia , Brazil"},{"name":"Federal University of Bahia School of Medicine \u00a0 , Salvador, Bahia , Brazil"},{"name":"Instituto Gon\u00e7alo Moniz \u00a0 , Salvador, Bahia , Brazil"},{"name":"Fiocruz \u00a0 , Salvador, Bahia , Brazil"},{"name":"National Institute of Science and Technology in Tropical Diseases \u00a0 , Salvador, Bahia , Brazil"},{"name":"CNPq\/MCT \u00a0 , Salvador, Bahia , Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,8,18]]},"reference":[{"key":"2023011110492939800_bib1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023011110492939800_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"2023011110492939800_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 Infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"2023011110492939800_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11940-008-0021-1","article-title":"Human T-lymphotropic virus 1\u00a0neurologic disease","volume":"10","author":"Araujo","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"2023011110492939800_bib5","first-page":"49","article-title":"Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)\u2013infected individuals without HTLV-1\u2013associated myelopathy\/tropical spastic paraparesis: a longitudinal cohort study","volume":"61","author":"Tanajura","year":"2015","journal-title":"Clin\u00a0Infect Dis"},{"key":"2023011110492939800_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2006.0140","article-title":"Clinical manifestations associated with HTLV type I infection: a cross-sectional study","volume":"23","author":"Caskey","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2023011110492939800_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcv.2011.02.004","article-title":"Clinical manifestations in individuals with recent diagnosis of HTLV type I infection","volume":"51","author":"Poetker","year":"2011","journal-title":"J\u00a0Clin Virol"},{"key":"2023011110492939800_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.urology.2007.01.052","article-title":"Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers","volume":"69","author":"Castro","year":"2007","journal-title":"Urology"},{"key":"2023011110492939800_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.urology.2009.11.041","article-title":"Prevalence of erectile dysfunction in HTLV-1\u2013infected patients and its association with overactive bladder","volume":"75","author":"Oliveira","year":"2010","journal-title":"Urology"},{"key":"2023011110492939800_bib10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1046\/j.1464-410x.2001.02211.x","article-title":"Vascular risk factors and erectile dysfunction","volume":"87","author":"Sullivan","year":"2001","journal-title":"BJU Int"},{"key":"2023011110492939800_bib11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/HCO.0000000000000174","article-title":"Erectile dysfunction and coronary heart disease","volume":"30","author":"Katsiki","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"2023011110492939800_bib12","first-page":"35","article-title":"[Erectile dysfunction\u2014incidence, causes and risk factors]","volume":"58","author":"Junuzovi\u0107","year":"2004","journal-title":"Med Arh"},{"key":"2023011110492939800_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.ijir.3901477","article-title":"Doppler evaluation of erectile dysfunction\u2014part 1","volume":"19","author":"Golijanin","year":"2007","journal-title":"Int J Impot Res"},{"key":"2023011110492939800_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.ijir.3901478","article-title":"Doppler evaluation of erectile dysfunction\u2014part 2","volume":"19","author":"Golijanin","year":"2007","journal-title":"Int J Impot Res"},{"key":"2023011110492939800_bib15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.ATV.19.4.972","article-title":"C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?","volume":"19","author":"Yudkin","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023011110492939800_bib16","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/hc0702.104279","article-title":"Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year","volume":"105","author":"Ziccardi","year":"2002","journal-title":"Circulation"},{"key":"2023011110492939800_bib17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3109\/1354750X.2015.1094141","article-title":"Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1\u2013associated disease morbidity","volume":"20","author":"Starling","year":"2015","journal-title":"Biomarkers"},{"key":"2023011110492939800_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2249.2008.03869.x","article-title":"Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1\u2013associated myelopathy\/tropical spastic paraparesis","volume":"156","author":"Nascimento","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2023011110492939800_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/jmv.23341","article-title":"Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection","volume":"84","author":"Santos","year":"2012","journal-title":"J\u00a0Med Virol"},{"key":"2023011110492939800_bib20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"2023011110492939800_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/aid.2006.22.931","article-title":"Proposal for diagnostic criteria of tropical spastic paraparesis\/HTLV-I\u2013associated myelopathy (TSP\/HAM)","volume":"22","author":"De Castro-Costa","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2023011110492939800_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"2023011110492939800_bib23","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"2023011110492939800_bib24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"2023011110492939800_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/2230-8210.149322","article-title":"Metabolic syndrome: an independent risk factor for erectile dysfunction","volume":"19","author":"Sanjay","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"key":"2023011110492939800_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"2023011110492939800_bib27","article-title":"Global Health Observatory (GHO)","author":"World Health Organization (WHO)"},{"key":"2023011110492939800_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0090-4295(01)01274-2","article-title":"Prevalence and correlates of erectile dysfunction: results of the Brazilian Study of Sexual Behavior","volume":"58","author":"Moreira","year":"2001","journal-title":"Urology"},{"key":"2023011110492939800_bib29","first-page":"5","article-title":"The epidemiology and pathophysiology of erectile dysfunction","volume":"161","author":"Melman","year":"1999","journal-title":"J\u00a0Urol"},{"key":"2023011110492939800_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11930-014-0023-9","article-title":"Current diagnosis and management of erectile dysfunction","volume":"6","author":"Pastuszak","year":"2014","journal-title":"Curr Sex Health Rep"},{"key":"2023011110492939800_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.ijir.3900949","article-title":"Epidemiology of erectile dysfunction","volume":"15","author":"Kubin","year":"2003","journal-title":"Int J Impot Res"},{"key":"2023011110492939800_bib32","first-page":"251","article-title":"Coronary artery risk factors in patients with erectile dysfunction","volume":"172","author":"El-Sakka","year":"2004","journal-title":"J\u00a0Urol"},{"key":"2023011110492939800_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/pmed.2000.0643","article-title":"Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study","volume":"30","author":"Feldman","year":"2000","journal-title":"Prev Med"},{"key":"2023011110492939800_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0094-0143(05)70139-7","article-title":"Neurologic erectile dysfunction","volume":"28","author":"Nehra","year":"2001","journal-title":"Urol Clin North Am"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609517313528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609517313528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/10\/1195\/48525234\/jsm_14_10_1195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/10\/1195\/48525234\/jsm_14_10_1195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T14:37:17Z","timestamp":1673447837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/14\/10\/1195\/6973347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,18]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,8,18]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.08.001","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,8,18]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Erectile Dysfunction in Men With HTLV-1","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}